Radiation therapy for large or treatment-resistant tumors
This trial tests a special type of radiation therapy for tumors that are large (over 4 cm) or have not responded to standard treatments. The goal is to see if this new approach can shrink tumors while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor that is larger than 4 cm, or a tumor that has not responded to standard treatments.
- Your tumor is not in a hollow organ (like the stomach or intestines) where bleeding or a tear is a significant risk.
- You are able to take care of yourself and are not severely confused or unconscious.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of radiation therapy and two immunotherapy drugs (Iparomlimab and Tuvonralimab) for people whose solid tumors have returned or spread and are too large for standard surgery. The goal is to shrink the tumor and control the cancer.
This trial tests a combination of low-dose radiation, focused high-dose radiation, and an immunotherapy drug (tislelizumab) for people with large, advanced solid tumors that have not responded to standard treatments.
This study tests whether combining a special type of radiation (spatial fragmentation) with low-dose radiation can help people whose lung cancer stopped responding to immunotherapy and chemotherapy. If you are eligible, you may receive a new treatment approach to try to shrink the tumors.
This trial tests combining two types of radiation therapy with an immunotherapy drug for people with advanced solid tumors that have spread or come back. The goal is to see if this approach can help when standard treatments have stopped working or aren’t an option.
This trial tests whether adding targeted radiation to your metastatic tumors can help your immunotherapy work better. It is for people with advanced solid tumors that have spread to 3-10 spots and who have been on immunotherapy for at least 3 months.
This trial tests a new type of radiation combined with immunotherapy for people with advanced solid tumors that are no longer responding to standard treatments or cannot tolerate them. The goal is to see if this combination can help control the disease.
Hear when a new Radiotherapy-Induced Immune Priming trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.